Filing Details
- Accession Number:
- 0001093557-18-000234
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-13 20:13:44
- Reporting Period:
- 2018-11-09
- Accepted Time:
- 2018-11-13 20:13:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534342 | Donald Abbey | 6340 Sequence Drive San Diego CA 92121 | Evp, Quality & Regulatory Afrs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-09 | 1,750 | $147.62 | 96,889 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-09 | 1,900 | $148.66 | 94,989 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-09 | 6,900 | $149.91 | 88,089 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $147.22 to $148.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected
- Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019.
- This transaction was executed in multiple trades at prices ranging from $148.22 to $149.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected
- This transaction was executed in multiple trades at prices ranging from $149.28 to $150.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected
Billionaire Hedge Funds
